MorphoSys AG (MOR)
NASDAQ: MOR · IEX Real-Time Price · USD
18.10
-0.06 (-0.33%)
At close: Jul 2, 2024, 4:00 PM
18.04
-0.06 (-0.33%)
After-hours: Jul 2, 2024, 5:14 PM EDT
MorphoSys AG Market Cap
MorphoSys AG has a market cap or net worth of $2.73 billion as of July 2, 2024. Its market cap has increased by 164.27% in one year.
Market Cap
2.73B
Enterprise Value
3.94B
1-Year Change
164.27%
Ranking
Category
Stock Price
$18.10
Market Cap Chart
Since April 19, 2018, MorphoSys AG's market cap has decreased from $3.05B to $2.73B, a decrease of -10.49%. That is a compound annual growth rate of -1.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 2.74B | 101.78% |
| Dec 29, 2023 | 1.36B | 177.16% |
| Dec 30, 2022 | 489.10M | -61.98% |
| Dec 31, 2021 | 1.29B | -64.36% |
| Dec 31, 2020 | 3.61B | -20.55% |
| Dec 31, 2019 | 4.54B | 42.25% |
| Dec 31, 2018 | 3.19B | 4.83% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Azenta | 2.84B |
| Inari Medical | 2.80B |
| SpringWorks Therapeutics | 2.79B |
| MoonLake Immunotherapeutics | 2.76B |
| TG Therapeutics | 2.75B |
| Progyny | 2.72B |
| agilon health | 2.69B |
| ACADIA Pharmaceuticals | 2.68B |